Allen Mooney & Barnes Investment Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53M Sell
6,437
-400
-6% -$83.1K 0.23% 62
2026
Q1
$1.44M Buy
6,837
+125
+2% +$26.9K 0.21% 62
2025
Q4
$1.38M Hold
6,712
0.21% 61
2025
Q3
$1.05M Buy
6,712
+102
+2% +$15.8K 0.16% 69
2025
Q2
$1.11M Sell
6,610
-144
-2% -$21.4K 0.18% 66
2025
Q1
$930K Sell
6,754
-90
-1% -$11.5K 0.15% 75
2024
Q4
$809K Sell
6,844
-47
-0.7% -$5.49K 0.14% 79
2024
Q3
$762K Hold
6,891
0.13% 79
2024
Q2
$678K Hold
6,891
0.12% 85
2024
Q1
$733K Hold
6,891
0.14% 81
2023
Q4
$695K Buy
6,891
+44
+0.6% +$4.37K 0.13% 82
2023
Q3
$594K Hold
6,847
0.13% 81
2023
Q2
$648K Hold
6,847
0.14% 77
2023
Q1
$517K Sell
6,847
-178
-3% -$13.4K 0.12% 81
2022
Q4
$540K Hold
7,025
0.13% 81
2022
Q3
$468K Sell
7,025
-345
-5% -$21.9K 0.13% 84
2022
Q2
$385K Hold
7,370
0.1% 102
2022
Q1
$418K Buy
+7,370
New +$395K 0.09% 109

Other funds holding CAH

Allen Mooney & Barnes Investment Advisors's CAH Position: Q2 2026 in Review

Allen Mooney & Barnes Investment Advisors reduced its Cardinal Health (CAH) stake by 5.9% in Q2 2026, selling an estimated $83.1K and leaving 6,437 shares worth $1.53M. The position accounts for 0.23% of the portfolio, ranked #62.

Allen Mooney & Barnes Investment Advisors first reported a position in CAH in Q1 2022 and has held it in 18 quarters since. 617 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Allen Mooney & Barnes Investment Advisors held 6,437 shares of Cardinal Health worth $1.53M as of Q2 2026.
  • Allen Mooney & Barnes Investment Advisors sold 400 Cardinal Health shares in Q2 2026, an estimated $83.1K.
  • Cardinal Health made up 0.23% of Allen Mooney & Barnes Investment Advisors's portfolio in Q2 2026, its #62 holding.
  • Allen Mooney & Barnes Investment Advisors first reported a position in Cardinal Health in Q1 2022 and has held it in 18 quarters since.
  • 617 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Allen Mooney & Barnes Investment Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.